ProMIS says PMN310 showed no ARIA-E in six-month Phase 1b interim data

Blinded PRECISE-AD results in 136 Alzheimer’s patients showed 4.4% total ARIA, all mild ARIA-H, with 12-month topline data expected in Q1 2027.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.